Harry H. Mansbach - Feb 1, 2024 Form 4 Insider Report for 89bio, Inc. (ETNB)

Role
Chief Medical Officer
Signature
/s/ Ryan A. Murr, as attorney-in-fact for Harry H. Mansbach
Stock symbol
ETNB
Transactions as of
Feb 1, 2024
Transactions value $
-$11,662
Form type
4
Date filed
2/5/2024, 08:22 PM
Previous filing
Jan 8, 2024
Next filing
Feb 13, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ETNB Common Stock Award $0 +48.8K +42.21% $0.00 164K Feb 1, 2024 Direct F1
transaction ETNB Common Stock Tax liability -$11.7K -1.19K -0.72% $9.80 163K Feb 5, 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ETNB Stock Option (Right to Buy) Award $0 +195K $0.00 195K Feb 1, 2024 Common Stock 195K $9.98 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs") that vest in equal semi-annual installments over three years, subject to the Reporting Person's continued service to the Issuer.
F2 These shares were withheld from the vesting of a performance-based RSU award to cover the estimated tax withholding obligation.
F3 This option represents a right to purchase a total of 195,000 shares of the Issuer's Common Stock, one quarter of which will vest on February 1, 2025, with the remaining three quarters vesting in equal quarterly installments over the following three years, subject to the Reporting Person's continued service to the Issuer.